Semaglutide/Cyanocobalamin Injectable Recalled for Lack of Sterility Assurance
Tailor Made Compounding is recalling 5,842 vials of compounded semaglutide/cyanocobalamin injectable due to lack of sterility assurance. The product was distributed nationwide in the United States and Puerto Rico.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a risk-of-harm product—an injectable medication that requires sterile manufacturing conditions. No illnesses or injuries have been reported. Per the severity rubric, risk-of-harm products where injury has not been reported are classified as High (score 3).
Plain-English summary
Tailor Made Compounding is recalling 5,842 vials of semaglutide/cyanocobalamin 2mg/0.4mg per milliliter in 1-milliliter vials. Multiple batch numbers are affected, with expiration dates ranging from March through June 2022.
The recall was issued due to lack of assurance of sterility. The manufacturer could not provide adequate verification that the product was manufactured under the required sterile conditions for injectable medications.
The affected product was distributed nationwide throughout the United States and Puerto Rico. Healthcare providers and patients who have received this product should be aware of the recall and verify which batch numbers they possess.
Patients and healthcare providers should contact their healthcare provider regarding any product they may have received. Do not use any remaining product from affected batches.
The recalled product
- Product
- Semaglutide/Cyanocobalamin 2mg/0.4mg/ml, 1mL-vial, Refrigerate, Tailor Made Compounding
- Manufacturer
- TMC Acquisition LLC dba Tailor Made Compounding
- Category
- Drug — Injectable / Compounded
- Affected units
- 5,842
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Batch#: 12032123A2
- Exp 3/3/2022
- 12102101A2
- Exp 3/10/2022
- 12202105A2
- Exp 3/20/2022
- 12292106A2
- Exp 3/29/2022
- 01062218B
- Exp 4/6/2022
- 01192228A2
- Exp 4/19/2022
- 01312214A2
- Exp 5/1/2022
- 02012211A1
- Exp 5/2/2022
- 02182201A1
- 02182203A1
- Exp 5/19/2022
- 02242205A1
Distribution
Part of a larger recall action
This product is one of 52 recalled by TMC Acquisition LLC dba Tailor Made Compounding under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 52 products in this recall →Related recalls
Same manufacturer · TMC Acquisition LLC dba Tailor Made Compounding
See all →- HighDexpanthenol Preservative Free Injectable Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-07-20
- HighHydroxocobalamin Compounded Injections Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20
- HighTailor Made Compounding Recalls Glycyrrhizic Acid Injectable for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20
- HighFDA Recalls Tailor Made Compounding GAC Injectable Vials for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20
- HighEstradiol Cypionate Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15